Galapagos(GLPG)

Search documents
Galapagos (GLPG) Investor Presentation - Slideshow
2019-06-05 16:46
Novel targets, better treatments Investor Presentation | June 2019 Disclaimer This presentation contains forward-looking statements, including (without limitation) statements concerning the progress of our clinical pipeline, the slides captioned "We go step by step on commercial" "Prolific late stage pipeline" "R&D ambition" "Filgotinib program" "FINCH summary up to w24" "Filgotinib: promising profile" "Inflammation market ~$65B by 2027" "$2.1B market with large unmet needs" "We are building a fibrosis port ...
Galapagos(GLPG) - 2019 Q1 - Earnings Call Transcript
2019-04-29 03:33
Galapagos NV (NASDAQ:GLPG) Q1 2019 Results Earnings Conference Call April 26, 2019 8:00 AM ET Company Participants Elizabeth Goodwin - VP of IR & Corporate Communications Onno van de Stolpe - Chief Executive Officer Bart Filius - CFO & COO Piet Wigerinck - Chief Scientific Officer Walid Abi-Saab - Chief Medical Officer Conference Call Participants Wimal Kapadia - Bernstein Eliana Merle - Cantor Fitzgerald Emily Field - Barclays Debjit Chattopadhyay - H.C. Wainwright James Quigley - JPMorgan Christopher Mara ...
Galapagos(GLPG) - 2018 Q4 - Annual Report
2019-03-29 21:05
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________ to __________ OR ☐ SHELL COMPANY REPORT PURSU ...
Galapagos(GLPG) - 2018 Q4 - Earnings Call Transcript
2019-02-22 20:12
Galapagos NV (NASDAQ:GLPG) Q4 2018 Earnings Conference Call February 22, 2019 8:00 AM ET Company Participants Elizabeth Goodwin - Investor Relations Onno van de Stolpe - Chief Executive Officer Bart Filius - Chief Operating Officer & Chief Financial Officer Walid Abi-Saab - Chief Medical Officer Piet Wigerinck - Chief Scientific Officer Conference Call Participants Brian Abrahams - RBC Capital Markets Wimal Kapadia - Bernstein Christopher Marai - Nomura Edwind Zhang - Stifel Lucy Codrington - Jefferies Phil ...